Bruce C Cozadd is Director of Jazz Pharmaceuticals plc. Currently has a direct ownership of 429,973 shares of JAZZ, which is worth approximately $55.3 Million. The most recent transaction as insider was on Dec 01, 2022, when has been sold 1,000 shares (Ordinary Shares) at a price of $157.0 per share, resulting in proceeds of $157,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 430K
1.83% 3M change
0.04% 12M change
Total Value Held $55.3 Million

BRUCE C COZADD Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 01 2022
SELL
Open market or private sale
$157,000 $157.0 p/Share
1,000 Reduced 0.27%
371,078 Ordinary Shares
Nov 10 2022
SELL
Open market or private sale
$300,000 $150.0 p/Share
2,000 Reduced 0.53%
372,028 Ordinary Shares
Oct 03 2022
SELL
Open market or private sale
$6,099,975 $135.0 p/Share
45,185 Reduced 10.78%
374,028 Ordinary Shares
Oct 03 2022
BUY
Exercise of conversion of derivative security
$3,719,573 $59.13 p/Share
62,905 Added 13.05%
419,213 Ordinary Shares
Sep 06 2022
SELL
Open market or private sale
$1,186,493 $154.03 p/Share
7,703 Reduced 2.12%
356,308 Ordinary Shares
Sep 06 2022
BUY
Exercise of conversion of derivative security
$573,561 $59.13 p/Share
9,700 Added 2.6%
363,011 Ordinary Shares
Aug 01 2022
SELL
Open market or private sale
$1,128,370 $154.55 p/Share
7,301 Reduced 2.02%
354,311 Ordinary Shares
Aug 01 2022
BUY
Exercise of conversion of derivative security
$513,906 $52.98 p/Share
9,700 Added 2.61%
361,612 Ordinary Shares
Jul 05 2022
SELL
Open market or private sale
$1,383,642 $157.68 p/Share
8,775 Reduced 2.43%
351,912 Ordinary Shares
Jul 05 2022
BUY
Exercise of conversion of derivative security
$454,251 $46.83 p/Share
9,700 Added 2.62%
360,687 Ordinary Shares
Jun 02 2022
SELL
Open market or private sale
$150,000 $150.0 p/Share
1,000 Reduced 0.28%
350,987 Ordinary Shares
Jun 01 2022
SELL
Open market or private sale
$939,158 $147.62 p/Share
6,362 Reduced 1.78%
351,987 Ordinary Shares
Jun 01 2022
BUY
Exercise of conversion of derivative security
$454,251 $46.83 p/Share
9,700 Added 2.64%
358,349 Ordinary Shares
May 02 2022
SELL
Open market or private sale
$1,140,764 $157.13 p/Share
7,260 Reduced 2.04%
348,502 Ordinary Shares
May 02 2022
BUY
Exercise of conversion of derivative security
$454,251 $46.83 p/Share
9,700 Added 2.65%
355,762 Ordinary Shares
Apr 04 2022
SELL
Open market or private sale
$1,703,807 $158.17 p/Share
10,772 Reduced 3.02%
346,062 Ordinary Shares
Apr 04 2022
BUY
Exercise of conversion of derivative security
$454,251 $46.83 p/Share
9,700 Added 2.65%
356,834 Ordinary Shares
Mar 17 2022
BUY
Exercise of conversion of derivative security
$76,159 $59.13 p/Share
1,288 Added 0.37%
347,134 Ordinary Shares
Mar 05 2022
SELL
Payment of exercise price or tax liability
$3,376,189 $153.96 p/Share
21,929 Reduced 5.96%
345,846 Ordinary Shares
Mar 03 2022
BUY
Grant, award, or other acquisition
-
44,788 Added 10.86%
367,775 Ordinary Shares
Mar 02 2022
SELL
Open market or private sale
$900,000 $150.0 p/Share
6,000 Reduced 1.82%
322,987 Ordinary Shares
Mar 01 2022
SELL
Open market or private sale
$888,167 $136.62 p/Share
6,501 Reduced 1.94%
328,987 Ordinary Shares
Mar 01 2022
BUY
Exercise of conversion of derivative security
$454,251 $46.83 p/Share
9,700 Added 2.81%
335,488 Ordinary Shares
Feb 01 2022
SELL
Open market or private sale
$886,982 $139.2 p/Share
6,372 Reduced 1.92%
325,788 Ordinary Shares
Feb 01 2022
BUY
Exercise of conversion of derivative security
$454,251 $46.83 p/Share
9,700 Added 2.84%
332,160 Ordinary Shares

Also insider at

SLRN
ACELYRIN, Inc.
BCC

Bruce C Cozadd

Director
Dublin 4, L2

Track Institutional and Insider Activities on JAZZ

Follow Jazz Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

News

Receive news related to Jazz Pharmaceuticals plc

Track Activities on JAZZ